CLINUVEL PHARMACEUT. ORDINARY (CUV) Short Interest
CLINUVEL PHARMACEUT. ORDINARY (ASX:CUV) had 9.47% of shares reported as short positions as of 26 June 2026, representing 4,776,124 shares. CLINUVEL PHARMACEUT. ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
CUV
Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals Ltd. is a pioneering Australian company specializing in the development of innovative treatments for UV and light-related skin disorders. Their flagship product, SCENESSE®, is the first systemic photoprotective drug approved for preventing phototoxicity in patients with erythropoietic protoporphyria. The company leverages its expertise in photomedicine and melanocortin pep...